CD158 receptor controls cytotoxic T-lymphocyte susceptibility to tumor-mediated activation-induced cell death by interfering with Fas signaling.

Source:http://linkedlifedata.com/resource/pubmed/id/14612548

Cancer Res. 2003 Nov 1 63 21 7475-82

Download in:

View as

General Info

PMID
14612548